Literature DB >> 3896289

The value of immunocytochemical methods in the differential diagnosis of anaplastic thyroid tumours.

N Ralfkiaer, K C Gatter, C Alcock, A Heryet, E Ralfkiaer, D Y Mason.   

Abstract

The practical usefulness of a panel of monoclonal antibodies recognising epithelial and lymphoid antigens has been evaluated on a series of 10 routinely processed thyroid tumours of uncertain origin. All 6 small cell tumours were shown to be of lymphoid origin whereas of the 4 large cell tumours two were lymphomas and two carcinomas. Two of the tumours, one large cell and one small cell, were undiagnosable due to technical reasons (crush artefact or small size of biopsy) and emphasized the value of immunohistology in this context. Clinical follow-up of all 10 cases indicated that these distinctions are of both prognostic and therapeutic value. It is concluded that immunocytochemistry using a carefully selected panel of monoclonal antibodies is a valuable and convenient means of making an objective distinction between anaplastic thyroid tumours of epithelial or lymphoid origin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896289      PMCID: PMC1977107          DOI: 10.1038/bjc.1985.173

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Diffuse small-cell carcinoma of the thyroid.

Authors:  W A MEISSNER; M J PHILLIPS
Journal:  Arch Pathol       Date:  1962-10

2.  Small cell tumors of the thyroid. A clinicopathologic study.

Authors:  E J Rayfield; R H Nishiyama; J C Sisson
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

3.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

4.  Use of monoclonal antibodies for the histopathological diagnosis of human malignancy.

Authors:  K C Gatter; Z Abdulaziz; P Beverley; J R Corvalan; C Ford; E B Lane; M Mota; J R Nash; K Pulford; H Stein; J Taylor-Papadimitriou; C Woodhouse; D Y Mason
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

5.  Malignant lymphoma of the thyroid.

Authors:  E D Williams
Journal:  Clin Endocrinol Metab       Date:  1981-07

6.  Malignant lymphomas and undifferentiated small cell carcinoma of the thyroid: a clinicopathological review in the light of the Kiel classification for malignant lymphomas.

Authors:  R Heimann; A Vannineuse; C De Sloover; P Dor
Journal:  Histopathology       Date:  1978-05       Impact factor: 5.087

7.  Reactivity pattern of a monoclonal antikeratin antibody (KL1).

Authors:  J Viac; A Reano; J Brochier; M J Staquet; J Thivolet
Journal:  J Invest Dermatol       Date:  1983-10       Impact factor: 8.551

8.  Malignant lymphoma and other lymphoproliferative disorders of the thyroid gland. A clinicopathologic study of 245 cases.

Authors:  J Compagno; J E Oertel
Journal:  Am J Clin Pathol       Date:  1980-07       Impact factor: 2.493

9.  Diagnosis of human lymphoma with monoclonal antileukocyte antibodies.

Authors:  R A Warnke; K C Gatter; B Falini; P Hildreth; R E Woolston; K Pulford; J L Cordell; B Cohen; C De Wolf-Peeters; D Y Mason
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

10.  Undifferentiated thyroid tumors of diffuse small cell type. Histological and immunohistochemical evidence for their lymphomatous nature.

Authors:  A Tobler; R Maurer; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.